BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 31264429)

  • 1. Changing Landscape of Clinical-Genomic Oncology Practice.
    Trivedi H; Kling HM; Treece T; Audeh W; Srkalovic G
    Acta Med Acad; 2019 Apr; 48(1):6-17. PubMed ID: 31264429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing precision cancer medicine in the genomic era.
    Chen HZ; Bonneville R; Roychowdhury S
    Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
    McGowan ML; Settersten RA; Juengst ET; Fishman JR
    Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
    Perera-Bel J; Hutter B; Heining C; Bleckmann A; Fröhlich M; Fröhling S; Glimm H; Brors B; Beißbarth T
    Genome Med; 2018 Mar; 10(1):18. PubMed ID: 29544535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision Medicine in Veterinary Science.
    Chon E; Hendricks W; White M; Rodrigues L; Haworth D; Post G
    Vet Clin North Am Small Anim Pract; 2024 May; 54(3):501-521. PubMed ID: 38212188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating genomics in cancer care.
    Bombard Y; Bach PB; Offit K
    J Natl Compr Canc Netw; 2013 Nov; 11(11):1343-53. PubMed ID: 24225968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician interpretation of genomic test results and treatment selection.
    Brusco LL; Wathoo C; Mills Shaw KR; Holla VR; Bailey AM; Johnson AM; Khotskaya YB; Litzenburger BC; Sanchez NS; Zeng J; Bernstam EV; Eng C; Kee BK; Amaria RN; Routbort MJ; Mills GB; Mendelsohn J; Meric-Bernstam F
    Cancer; 2018 Mar; 124(5):966-972. PubMed ID: 29165790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Art and Challenges of Precision Medicine: Interpreting and Integrating Genomic Data Into Clinical Practice.
    Madhavan S; Subramaniam S; Brown TD; Chen JL
    Am Soc Clin Oncol Educ Book; 2018 May; 38():546-553. PubMed ID: 30231369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
    Holch JW; Westphalen CB; Hiddemann W; Heinemann V; Jung A; Metzeler KH
    Dtsch Med Wochenschr; 2017 Nov; 142(22):1676-1684. PubMed ID: 29078213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.
    Piñeiro-Yáñez E; Reboiro-Jato M; Gómez-López G; Perales-Patón J; Troulé K; Rodríguez JM; Tejero H; Shimamura T; López-Casas PP; Carretero J; Valencia A; Hidalgo M; Glez-Peña D; Al-Shahrour F
    Genome Med; 2018 May; 10(1):41. PubMed ID: 29848362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic medicine: new frontiers and new challenges.
    Pasic MD; Samaan S; Yousef GM
    Clin Chem; 2013 Jan; 59(1):158-67. PubMed ID: 23284016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenging Standard-of-Care Paradigms in the Precision Oncology Era.
    Subbiah V; Kurzrock R
    Trends Cancer; 2018 Feb; 4(2):101-109. PubMed ID: 29458960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance.
    Casolino R; Beer PA; Chakravarty D; Davis MB; Malapelle U; Mazzarella L; Normanno N; Pauli C; Subbiah V; Turnbull C; Westphalen CB; Biankin AV
    CA Cancer J Clin; 2024; 74(3):264-285. PubMed ID: 38174605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
    Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
    Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer genomics and clinical practice: how can we close the gap more quickly?
    Konecny GE
    Curr Opin Obstet Gynecol; 2017 Feb; 29(1):1-3. PubMed ID: 27941363
    [No Abstract]   [Full Text] [Related]  

  • 18. Pilot studies for personalized cancer medicine: focusing on the patient for treatment selection.
    De Mattos-Arruda L; Rodon J
    Oncologist; 2013; 18(11):1180-8. PubMed ID: 24136009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.
    Hall WA; Bergom C; Thompson RF; Baschnagel AM; Vijayakumar S; Willers H; Li XA; Schultz CJ; Wilson GD; West CML; Capala J; Coleman CN; Torres-Roca JF; Weidhaas J; Feng FY
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):274-284. PubMed ID: 28964588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
    Mitropoulos K; Cooper DN; Mitropoulou C; Agathos S; Reichardt JKV; Al-Maskari F; Chantratita W; Wonkam A; Dandara C; Katsila T; Lopez-Correa C; Ali BR; Patrinos GP
    OMICS; 2017 Nov; 21(11):647-657. PubMed ID: 29140767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.